Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
MONTVALE, N.J. - The U.S. Food and Drug Administration has approved a new drug application for a cream designed to treat vaginal dryness and pain from intercourse, Barr Pharmaceuticals Inc. said Monday.
| BRL | 65.8 |  -1.19 |
Synthetic Conjugated Estrongens-A Vaginal Cream will be available by prescription in the first quarter of next year.
The plant-derived cream is designed to treat symptoms of vulvar and vaginal atrophy due to menopause. It was developed by Barr subsidiary Duramed Pharmaceuticals Inc.
Barr stock fell 89 cents to $64.48 in morning trading.
You've heard the talk of "Green" throughout the whole of 2008, bu...
South Korea said Tuesday it will invest 50 trillion won ($38.1 billion) over the next four years on environmental projects in a "Green New D...
The pullback to 1.2070 was quite deep but this resistance capped as expected but we really need a break below 1.1755 to sustain the move lower no...
AdMob, the world's largest and fastest growing mobile advertising marketplace, today la...
Buy Real Estate, Tax Liens, and more- Fund your business or franchise without debt
Get your next web design project done with our los angeles web design team - Best web design with great price.
Building your business and corporate credit for your small business.
Partners   
|
© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
